1299 Radiomics features to predict tumor response and biomarker status in non-small cell lung cancer (NSCLC) patients treated with immunotherapy

Documenti analoghi

• 1299 Radiomics features to predict tumor response and biomarker status in non-small cell lung cancer (NSCLC) patients treated with immunotherapy
  di: Young Kwang Chae, et al.
  Pubblicazione: (2023-11-01)
• Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
  di: Youjin Oh, et al.
  Pubblicazione: (2024-01-01)
• 38 Serum proteomics signature and its association with immune-related toxicities and survival in patients with non-small cell lung cancers (NSCLC) receiving immunotherapy
  di: Young Kwang Chae, et al.
  Pubblicazione: (2023-11-01)
• CIP
  di: - -
  Pubblicazione: (2012-12-01)
• UCHL1 Promotes Gastric Cancer Progression by Regulating CIP2A Degradation
  di: Ga-ye Lee, et al.
  Pubblicazione: (2025-09-01)